External Event: 2026 ADAI Symposium

This external webinar is hosted by University of Washington Addictions, Drug & Alcohol Institute.
The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream
September 18, 2026 | 9:00am – 4:00pm PT | FREE EVENT
Attend virtually or in person at the UW Tower Auditorium in Seattle
Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance.
In a recent survey of Washington State healthcare providers, 70% reported treating patients experiencing severe abdominal pain, persistent nausea, retching, and relentless vomiting associated with heavy cannabis use. Patients may not recognize cannabis as the cause of their symptoms, or may be skeptical that CHS exists at all, making effective care even more challenging.
View program | Register | Submit abstract for a digital poster (due Aug 18)
Join the UW Addictions, Drug & Alcohol Institute (ADAI) on September 18, 2026, to for this FREE one-day symposium about:
- What we know about CHS in Washington State and the U.S.—prevalence in hospitals, emergency departments, and community settings
- Recognition, diagnosis, treatment, and management across healthcare settings
- Policy strategies to reduce CHS and clinical strategies to increase CHS awareness and acceptance
Whether you work in primary care, emergency medicine, behavioral health, nursing, pharmacy, or public health, this symposium will help you better understand, recognize, manage, and communicate about this important cannabis-related health condition.
CME accreditation pending for providers; Certificate of attendance available for both in-person and virtual attendees


